CDCP1

Across TCGA pan-cancer cohorts, CDCP1 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated CDCP1 data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CDCP1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CDCP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

CCRCC, PDAC, and LUAD are the cancer types where CDCP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.723	0.948	<.001	73	view →
PDAC	DFS	Median	II,III,IV	0.644	0.910	<.001	34	view →
LUAD	DFS	Quartile	All	0.265	0.814	<.001	20	view →
GBM	OS	Tertile	All	0.360	0.707	.001	17	view →
HNSC	DFS	Tertile	II,III,IV	0.985	0.858	.010	14	view →
COAD	DFS	Median	IV	0.565	1.000	.028	6	view →
LSCC	DFS	Median	II,III,IV	0.988	0.848	.046	1	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

CDCP1–CCRCC (OS)

Open the CCRCC breakdown →